Volume 61, Issue 1 pp. 1-4
Original Article
Free Access

A novel 105 basepair deletion causing β0-thalassemia in members of a Thai family

Chamnong Nopparatana

Corresponding Author

Chamnong Nopparatana

Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Ph.D., Department of Pathology, Faculty of Medicine, Prince of Songkla University, Hat-Yai, Songkhla 90110, ThailandSearch for more papers by this author
Vannarat Saechan

Vannarat Saechan

Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Search for more papers by this author
Chawadee Nopparatana

Chawadee Nopparatana

Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Search for more papers by this author
Malida Pornpatkul

Malida Pornpatkul

Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Search for more papers by this author
Vicharn Panich

Vicharn Panich

Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Search for more papers by this author
Yasuyuki Fukumaki

Yasuyuki Fukumaki

Institute of Genetic Information, Division of Disease Genes, Kyushu University, Fukuoka, Japan

Search for more papers by this author

Abstract

We identified and characterized a novel β0-thalassemia mutation due to partial deletion of the 5′ end β-globin gene including the mRNA cap site and a part of exon 1. The deletion was precisely 105 basepair (bp) in length extending from position −24 or −25 to +80 or +81 relative to the β-globin gene mRNA cap site. This mutation was detected in three individuals from a family originating in the area of southern Thailand. The propositus was a 39-year-old female and noted to be heterozygous for β-thalassemia with hemoglobin (Hb) level of 10.1 g/dl, MCV 70 fl, MCH 23.1 pg, HbA2 6.3%, and HbF 2.4%. Her son was 9 years of age and was also heterozygous for the mutation, having Hb level of 10.8 g/dl, MCV 58 fl, MCH 19.0 pg, HbA2 5.6%, and HbF 4.3%. Her 6-year-old daughter was affected, having a genotype of this mutation and a G-C transition at IVS 1 nt 5. Although the deletion does not include the β-globin gene promoter sequences, the individuals heterozygous for this mutation have an elevated HbA2 level slightly higher than observed in most carriers of β-thalassemia caused by point mutations. Am. J. Hematol. 61:1–4, 1999. © 1999 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.